K. Yamaguchi et al., EFFECT OF 6-HYDROXYDOPAMINE INJECTION INTO THE ARCUATE HYPOTHALAMIC NUCLEUS ON THE OSMOTIC RELEASE OF VASOPRESSIN IN CONSCIOUS RATS, European journal of endocrinology, 131(6), 1994, pp. 658-663
The aim of the present study was to evaluate a role in vasopressin sec
retion of the catecholaminergic neurons, including the tuberohypophysi
al dopaminergic neurons situated in the arcuate hypothalamic nucleus.
A neurotoxin, 6-hydroxydopamine (6 g/l), was injected locally into the
arcuate nucleus and its effects on catecholamine levels of the hypoth
alamic tissue and the neurointermediate lobe, and on the plasma vasopr
essin concentrations before and during iv infusion (0.1 ml kg(-1) min(
-1)) of isotonic (0.15 mol/l) or hyper-tonic saline (2.5 mol/l), were
examined in conscious rats. The infusion of hyper-tonic saline produce
d increases of plasma vasopressin 15 and 30 min later, accompanied by
elevations of plasma osmolality, sodium, chloride and arterial pressur
e. The vasopressin response was potentiated markedly by the 6-hydroxyd
opamine injection performed 8 days before, which hardly affected the r
esponses of the other variables. Histological examination indicated th
at the injection sites of 6-hydroxydopamine in those rats had been loc
ated in the area ranging from rostral to medial arcuate nucleus. The i
v infusion of isotonic saline did not change plasma vasopressin, osmol
ality, sodium, chloride or arterial pressure, regardless of the presen
ce or absence of pretreatment with 6-hydroxydopamine. It was confirmed
that when 6-hydroxydopamine was injected into the arcuate nucleus reg
ion 8 days before, noradrenaline and adrenaline concentrations of the
hypoathalamic tissue containing the injection site were decreased rema
rkably, although we could not detect any significant alteration in the
dopamine concentration of the hypothalamic tissue or the neurointerme
diate lobe. On the basis of these results, we concluded that catechola
minergic neurons in the arcuate nucleus may act to inhibit osmotic vas
opressin secretion.